Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Stagezero Life Sciences Ltd (SZLSF)

Stagezero Life Sciences Ltd (SZLSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Stagezero Life Sciences Ltd 70 East Beaver Creek Road Unit 30 Richmond Hill A6 L4B 3B2 CAN

www.stagezerolifesciences.com P: 905-209-2030

Description:

StageZero Life Sciences Ltd is dedicated to the early detection of cancer and multiple disease states through whole blood. The company's test consists of Aristotle(R), a multi-cancer panel for simultaneously screening for cancers from a single sample of blood. StageZero Life Sciences Ltd, formerly known as GeneNews Ltd., is based in TORONTO, ON.

Key Statistics

Overview:

Market Capitalization, $K 1,581
Enterprise Value, $K 2,321
Shares Outstanding, K 123,533
Annual Sales, $ 3,800 K
Annual Net Income, $ -11,420 K
Last Quarter Sales, $ 750 K
Last Quarter Net Income, $ -820 K
EBIT, $ -4,550 K
EBITDA, $ -4,310 K
60-Month Beta 0.58
% of Insider Shareholders 2.54%
% of Institutional Shareholders 0.00%
Float, K 120,395
% Float 97.46%
Short Volume Ratio 1.00

Growth:

1-Year Return -79.78%
3-Year Return -97.86%
5-Year Return -95.74%
5-Year Revenue Growth 826.83%
5-Year Earnings Growth 54.17%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 11/14/23
Latest Earnings Date 05/20/24
Earnings Per Share ttm -0.12
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 09/18/20

SZLSF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -300.53%
Debt/Equity -0.13
Price/Sales 0.53
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.07
Interest Coverage -39.79
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar